Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Alama

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|October 15, 1987
Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic resultsP F Conte, A Alama, G Bertelli, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|December 17, 2002
[Bilateral primary adrenal lymphoma: an unusual presentation]M A Alama Zaragoza, A Robles Iniesta, I Roca Adelantado, et al.
Expert Opinion on Investigational Drugs|November 3, 2016
Vinflunine for the treatment of non-small cell lung cancerC Genova, A Alama, S Coco, et al.
Cellular and Molecular Life Sciences : CMLS|February 25, 2014
Role of microRNAs in malignant mesotheliomaA Truini, S Coco, A Alama, et al.
International Journal of Cancer|June 20, 2015
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitorsM G Dal Bello, A Alama, G Barletta, et al.
Journal of Translational Medicine|March 10, 2019
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patientsM G Dal Bello, R A Filiberti, A Alama, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 13, 2020
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatmentA Bonaventura, F Grossi, F Carbone, et al.
JMIR Cardio|May 20, 2026
Postangiography Prediction of Renal Replacement Therapy in Acute Myocardial Infarction-Related Cardiogenic Shock: Least Absolute Shrinkage and Selection Operator Nomogram Development and ValidationAmin Daoulah, Julia M Ladna, Abdulrahman Arabi, et al.
Shock (Augusta, Ga.)|March 18, 2025
RIGHT VENTRICULAR DYSFUNCTION AS A MORTALITY DETERMINANT FOR PATIENTS WITH CARDIOGENIC SHOCK INDUCED BY ACUTE MYOCARDIAL INFARCTIONAmin Daoulah, Shaber Seraj, Ahmed Elmahrouk, et al.
Angiology|March 2, 2026
Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial InfarctionAmin Daoulah, Rishard Abdul, Ahmed Elmahrouk, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|October 15, 1987
Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic resultsP F Conte, A Alama, G Bertelli, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|December 17, 2002
[Bilateral primary adrenal lymphoma: an unusual presentation]M A Alama Zaragoza, A Robles Iniesta, I Roca Adelantado, et al.
Expert Opinion on Investigational Drugs|November 3, 2016
Vinflunine for the treatment of non-small cell lung cancerC Genova, A Alama, S Coco, et al.
Cellular and Molecular Life Sciences : CMLS|February 25, 2014
Role of microRNAs in malignant mesotheliomaA Truini, S Coco, A Alama, et al.
International Journal of Cancer|June 20, 2015
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitorsM G Dal Bello, A Alama, G Barletta, et al.
Journal of Translational Medicine|March 10, 2019
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patientsM G Dal Bello, R A Filiberti, A Alama, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 13, 2020
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatmentA Bonaventura, F Grossi, F Carbone, et al.
JMIR Cardio|May 20, 2026
Postangiography Prediction of Renal Replacement Therapy in Acute Myocardial Infarction-Related Cardiogenic Shock: Least Absolute Shrinkage and Selection Operator Nomogram Development and ValidationAmin Daoulah, Julia M Ladna, Abdulrahman Arabi, et al.
Shock (Augusta, Ga.)|March 18, 2025
RIGHT VENTRICULAR DYSFUNCTION AS A MORTALITY DETERMINANT FOR PATIENTS WITH CARDIOGENIC SHOCK INDUCED BY ACUTE MYOCARDIAL INFARCTIONAmin Daoulah, Shaber Seraj, Ahmed Elmahrouk, et al.
Angiology|March 2, 2026
Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial InfarctionAmin Daoulah, Rishard Abdul, Ahmed Elmahrouk, et al.
Pageof 6